Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evidence

J Clin Oncol. 2019 Aug 1;37(22):1863-1867. doi: 10.1200/JCO.18.02118. Epub 2019 Apr 17.
No abstract available

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / complications
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Clinical Decision-Making
  • Decision Support Systems, Clinical
  • Drug Approval
  • Humans
  • Immunologic Factors / therapeutic use
  • Immunotherapy / methods*
  • Immunotherapy / standards
  • Lung Neoplasms / complications
  • Lung Neoplasms / therapy*
  • Medical Oncology / standards
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive / complications
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • United States

Substances

  • Immunologic Factors